Latest filing published 23 Jun 2025 for Recursion Pharmaceuticals, INC..
Insider track record
No signal scores available.
Franziska Michor: trading record in brief
Franziska Michor discloses dealings in Recursion Pharmaceuticals, Inc. to SEC (Form 4). The record holds 5 filings, for trades running from 20 November 2024 to 18 June 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 23 June 2025 came the latest disclosure, a share grant in Recursion Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Franziska Michor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,016 shares0Class A Common StockSEC:0001601830-25-000111:0
- 15,335 shares0Class A Common StockSEC:0001601830-24-000221:1
- 17,694 shares0Class A Common StockSEC:0001601830-24-000221:2
- 41,390 shares0Class A Common StockSEC:0001601830-24-000221:3
- 30,618 sharesClass A Common StockSEC:0001601830-24-000221:0
5 of 5 declarations
